Investor Relations

For further information, please contact:
Phone: +1(608)831-4445
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Financial Statements & MDA

2024	Financial Statements for the period ending June 30, 2024
	MD&A for the period ending June 30, 2024 MDA
	Financial Statements for the period ending March 31, 2024
	MD&A for the period ending March 31, 2024 MDA
2023	Financial Statements for the period ending December 31, 2023
	MD&A for the period ending December 31, 2023
	Financial Statements for the period ending September 30, 2023
	MD&A for the period ended September 30, 2023
	Financial Statements for the period ending June 30, 2023
	MD&A for the period ended June 30, 2023
	Financial Statements for the period ending March 31, 2023
	MD&A for the period ended March 31, 2023
2022	Financial Statements for the period ending December 31, 2022
	MD&A for the period ended December 31, 2022
	Financial Statements for the period ending September 30, 2022
	MD&A for the period ended September 30, 2022
	Financial Statements for the period ending June 30, 2022
	MD&A for the period ended June 30, 2022
	Financial Statements for the period ending March 31, 2022
	MD&A for the period ended March 31, 2022
2021	Financial Statements for the period ending December 31, 2021
	MD&A for the period ended December 31, 2021
	Financial Statements for the period ending September 30, 2021
	MD&A for the period ended September 30, 2021
	Financial Statements for the period ending June 30, 2021
	MD&A for the period ended June 30, 2021
	Financial Statements for the period ending March 31, 2021
	MD&A for the period ended March 31, 2021
2020	Financial Statements for the period ending December 31, 2020
	MD&A for the period ended December 31, 2020
	Financial Statements for the period ending September 30, 2020
	MD&A for the period ended September 30, 2020
	Financial Statements for the period ending June 30, 2020
	MD&A for the period ended June 30, 2020
	Financial Statements for the period ending March 31, 2020
	MD&A for the period ended March 31, 2020
2019	Financial Statements for the period ending December 31, 2019
	MD&A for the period ended December 31, 2019
	Q3 Financial Statements for the period ending September 30, 2019
	Q3 MD&A for the period ended September 30, 2019
	Q2 Financial Statements for the period ending June 30, 2019
	Q2 MD&A for the period ended June 30, 2019
	Q1 Financial Statements for the period ending March 31, 2019
	Q1 MD&A for the period ended March 31, 2019
2018	Financial Statements for the period ending December 31, 2018
	MD&A for the period ended December 31, 2018
	Q3 Financial Statements for the period ending Sep 30, 2018
	Q3 MD&A for the period ended Sep 30, 2018
	Q2 Financial Statements for the period ending June 30, 2018
	Q2 MD&A for the period ended June 30, 2018
	Q1 Financial Statements for the period ending March 31, 2018
	Q1 MD&A for the period ended March 31, 2018
2017	Financial Statements for the period ending December 31, 2017
	MD&A for the period ended December 31, 2017
	Q3 Financial Statements for the period ending September 30, 2017
	Q3 MD&A for the period ended September 30, 2017
	Q2 Financial Statements for the period ending June 30, 2017
	Q2 MD&A for the period ended June 30, 2017
	Q1 Financial Statements for the period ending March 31, 2017
	Q1 MD&A for the period ending March 31, 2017
2016	Financial Statements for the period ending December 31, 2016
	MD&A for the period ended December 31, 2016
	Q3 Interim Financial Statements for the period ending September 30, 2016
	Q3 MD&A for the period ended September 30, 2016
	Q2 Interim Financial Statements for the period ending June 30, 2016
	Q2 MD&A for the period ended June 30, 2016
	Q1 Interim Financial Statements for the period ending March 31, 2016
	Q1 MD&A for the period ended March 31, 2016
2015	Financial Statements for the period ending December 31, 2015
	MD&A for the period ending December 31, 2015
	Q3 Interim Financial Statements for the period ending September 30, 2015
	Q3 MD&A for the period ending September 30, 2015
	Q2 Interim Financial Statements for the period ending June 30, 2015
	Q2 MD&A for the period ending June 30, 2015
	Q1 Interim Finacial Statements for the period ending March 31, 2015
	Q1 MD&A for the period ended March 31, 2015
2014	Audited annual financial statements
	Q3 Interim Consolidated Financial Statements for the period ended September 30, 2014
	Q3 MD&A for the period ended September 30, 2014
	Q2 Interim Consolidated Financial Statements for the period ended June 30, 2014
	Q2 MD&A for the period ended June 30, 2014
	Q1 Interim Consolidated Financial Statements for the period ended March 31, 2014
2013	Audited Consolidated Financial Statements
	Q3 Interim Consolidated Financial Statements for the period ended September 30, 2013
	Q3 Management's Discussion and Analysis, period ended September 30, 2013
	Q2 Interim Consolidated Financial Statements for the period ended June 30, 2013
	Q2 Management's Discussion and Analysis, period ended June 30, 2013
	Q1 Interim Consolidated Financial Statements for the period ended March 31, 2013
	Q1 Management's Discussion and Analysis, period ended March 31, 2013
2012	Annual Audited Consolidated Financial Statements December 31, 2012
	MD&A for the year ended December 31, 2012
	Q3 Interim Financial Statements for the period ending September 30, 2012
	Q3 MD&A for the period ended September 30, 2012

Shareholder Documents

2024	2023 Supply Chain Act Annual Report
2019	Notice of Annual and Special Meeting of Shareholders
2019	Go to sedar.com to download Mailing Card, Management Information Circular and Form of Proxy
2018	Notice of Annual and Special Meeting of Shareholders
2018	Go to sedar.com to download Mailing Card, Management Information Circular and Form of Proxy
2017	Notice of Annual and Special Meeting of Shareholders
	Go to sedar.com to download Mailing Card, Management Information Circular and Form of Proxy
	Wi2Wi Announces Closing of Private Placement of Units
2016	Management Information Circular
	Form of Proxy
	Notice of Meeting
2015	Management Information Circular
2015	Form of Proxy
2014	Letter to Shareholders
	Mailing Card
	Management Information Circular
	Form of Proxy

Analyst Coverage

Firm	Analyst	Website
Fundamental Research Corporation	Siddharth Rajeev, B.Tech (Electronics Engineering), MBA (Finance), CFA	http://www.researchfrc.com
Dr.Kalliwoda Research	Norbert Kalliwoda	http://www.kalliwoda.com

Fundamental Research Corporation	DR. KALLIWODA INTERNATIONAL RESEARCH GmbH
Suite 308 - 1155 West Pender Street Vancouver, BC V6E 2P4 Canada Tel.: Phone: 604-682-7050 Fax: 604-682-7001 E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.	Steinstrasse 24 D-64839 Münster Germany Office Frankfurt: Arndtstrasse 47 D-60325 Frankfurt am Main Germany Tel.: +49 69. 972 058 53 Fax: +49 69. 138 192 15 E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Fundamental Research Corporation

DR. KALLIWODA INTERNATIONAL RESEARCH GmbH

Suite 308 - 1155 West Pender Street
Vancouver, BC V6E 2P4
Canada
Tel.: Phone: 604-682-7050
Fax: 604-682-7001
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Steinstrasse 24
D-64839 Münster
Germany

Office Frankfurt:
Arndtstrasse 47
D-60325 Frankfurt am Main
Germany
Tel.: +49 69. 972 058 53
Fax: +49 69. 138 192 15
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Wi2Wi is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Wi2Wi's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Wi2Wi or its management. Wi2Wi does not, by its reference above, imply its endorsement of or concurrence with such information, conclusions or recommendations.

Investor Relations

Financial Statements & MDA

Shareholder Documents

Analyst Coverage

About Wi2Wi

Resources

Global Contacts